Renata Medical Completes Series A Financing

Renata Medical, Inc. completed the first two tranches of its Series A Preferred Stock Financing for net proceeds of just over $3.2 Million, including the conversion of outstanding debt. Renata Medical expects the entire financing round will yield approximately $5,250,000 in proceeds to finance additional clinical studies and general corporate needs.

Renata Medical is focused on the development of purposeful medical devices for unmet pediatric needs.  Its first product is a congenital heart stent implanted in newborns, which has the ability to grow with the child into adulthood and eliminate the need for repeated pediatric surgeries.